Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
Domain-

SCUBE1 C1R ZZEF1 PCOLCE

2.32e-05526042.60.120.290
DomainCUB_dom

SCUBE1 C1R ZZEF1 PCOLCE

3.35e-0557604IPR000859
DomainKazal_2

C6 SMOC1 SPINK5

2.09e-0436603PF07648
DomainKAZAL

C6 SMOC1 SPINK5

4.34e-0446603SM00280
DomainCUB

SCUBE1 C1R PCOLCE

5.23e-0449603PF00431
DomainKAZAL_2

C6 SMOC1 SPINK5

5.55e-0450603PS51465
DomainCUB

SCUBE1 C1R PCOLCE

5.55e-0450603SM00042
DomainKazal_dom

C6 SMOC1 SPINK5

5.88e-0451603IPR002350
DomainCUB

SCUBE1 C1R PCOLCE

6.59e-0453603PS01180
DomainKazal_1

SMOC1 SPINK5

2.25e-0322602PF00050
DomainEGF_CA

SCUBE1 LRP1 C1R

2.67e-0386603PF07645
DomainPAS-assoc_C

PER2 KCNH2

2.68e-0324602IPR000700
DomaincEGF

SCUBE1 LRP1

3.14e-0326602IPR026823
DomainPAC

PER2 KCNH2

3.14e-0326602IPR001610
DomaincEGF

SCUBE1 LRP1

3.14e-0326602PF12662
DomainPAC

PER2 KCNH2

3.14e-0326602SM00086
DomainPAC

PER2 KCNH2

3.14e-0326602PS50113
DomainEGF_Ca-bd_CS

SCUBE1 LRP1 C1R

3.75e-0397603IPR018097
DomainEGF_CA

SCUBE1 LRP1 C1R

3.97e-0399603PS01187
DomainASX_HYDROXYL

SCUBE1 LRP1 C1R

4.09e-03100603PS00010
DomainDUSP

SSH1 DUSP7

4.44e-0331602IPR024950
DomainPAS

PER2 KCNH2

4.73e-0332602SM00091
DomainEGF-type_Asp/Asn_hydroxyl_site

SCUBE1 LRP1 C1R

4.81e-03106603IPR000152
DomainPAS

PER2 KCNH2

5.33e-0334602IPR000014
DomainTYR_PHOSPHATASE_DUAL

SSH1 DUSP7

5.33e-0334602PS50054
DomainPAS

PER2 KCNH2

5.33e-0334602PS50112
DomainTYR_PHOSPHATASE_DUAL_dom

SSH1 DUSP7

5.64e-0335602IPR020422
DomainDSPc

SSH1 DUSP7

5.64e-0335602SM00195
DomainEGF_3

SCUBE1 LRP1 C1R C6

6.87e-03235604PS50026
DomainEGF_CA

SCUBE1 LRP1 C1R

7.10e-03122603SM00179
DomainLDLR_class-A_CS

LRP1 C6

7.32e-0340602IPR023415
DomainEGF-like_Ca-bd_dom

SCUBE1 LRP1 C1R

7.42e-03124603IPR001881
DomainDual-sp_phosphatase_cat-dom

SSH1 DUSP7

7.68e-0341602IPR000340
DomainDSPc

SSH1 DUSP7

7.68e-0341602PF00782
DomainEGF-like_dom

SCUBE1 LRP1 C1R C6

8.39e-03249604IPR000742
DomainEGF_1

SCUBE1 LRP1 C1R C6

9.10e-03255604PS00022
DomainLdl_recept_a

LRP1 C6

9.19e-0345602PF00057
Pubmed

The after-hours mutant reveals a role for Fbxl3 in determining mammalian circadian period.

PER2 FBXL3

3.13e-06262217463252
Pubmed

Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.

LRP1 ADAM10

3.13e-06262227503326
Pubmed

Phosphorylation of GAPVD1 Is Regulated by the PER Complex and Linked to GAPVD1 Degradation.

GAPVD1 PER2

3.13e-06262233917494
Pubmed

Delayed Cryptochrome Degradation Asymmetrically Alters the Daily Rhythm in Suprachiasmatic Clock Neuron Excitability.

PER2 FBXL3

3.13e-06262228698388
Pubmed

Increased TIMP-3 expression alters the cellular secretome through dual inhibition of the metalloprotease ADAM10 and ligand-binding of the LRP-1 receptor.

LRP1 ADAM10

9.37e-06362230279425
Pubmed

A Cryptochrome 2 mutation yields advanced sleep phase in humans.

PER2 FBXL3

9.37e-06362227529127
Pubmed

Distinct and separable roles for endogenous CRY1 and CRY2 within the circadian molecular clockwork of the suprachiasmatic nucleus, as revealed by the Fbxl3(Afh) mutation.

PER2 FBXL3

1.87e-05462223616524
Pubmed

Oxyntomodulin regulates resetting of the liver circadian clock by food.

PER2 GLP1R

1.87e-05462225821984
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

TLNRD1 PER2 MAP1S SSH1 KCNH2 SGSM2 NLGN2 ZZEF1 LYST MAPK8IP3

2.41e-051105621035748872
Pubmed

PTPRA Phosphatase Regulates GDNF-Dependent RET Signaling and Inhibits the RET Mutant MEN2A Oncogenic Potential.

NUMBL ANKLE2 ADAM10 PTK7

2.48e-059462432062451
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

DMXL2 MYH11 SSH1 N4BP2 IP6K1 NLGN2 TUBGCP5

2.76e-0549362715368895
Pubmed

Association of the 3' UTR transcription factor LBP-1c/CP2/LSF polymorphism with late-onset Alzheimer's disease.

LRP1 C1R

3.12e-05562212555245
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

DHX36 GAPVD1 PLPPR4 HAUS5 ANKRD50 ZZEF1 ANKLE2

4.32e-0552962714621295
Pubmed

SCF(FBXL3) ubiquitin ligase targets cryptochromes at their cofactor pocket.

PER2 FBXL3

4.67e-05662223503662
Pubmed

Distinct Roles of HDAC3 in the Core Circadian Negative Feedback Loop Are Critical for Clock Function.

PER2 FBXL3

4.67e-05662226776516
Pubmed

Circadian mutant Overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression.

PER2 FBXL3

4.67e-05662217462724
Pubmed

Competing E3 ubiquitin ligases govern circadian periodicity by degradation of CRY in nucleus and cytoplasm.

PER2 FBXL3

6.53e-05762223452855
Pubmed

FBXL21 regulates oscillation of the circadian clock through ubiquitination and stabilization of cryptochromes.

PER2 FBXL3

6.53e-05762223452856
Pubmed

PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase.

DHX36 GAPVD1 MAP1S CLINT1 ZZEF1

8.07e-0524762532989298
Pubmed

Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.

SSH1 N4BP2 BOD1L1 NLGN2

1.65e-0415362410718198
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

GAPVD1 NUMBL SRP72 BOD1L1 CLINT1 ANKRD50 ANKLE2

2.62e-0470862739231216
Pubmed

SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins.

PER2 FBXL3

2.81e-041462217463251
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

DMXL2 SSH1 PLPPR4 NUMBL N4BP2 LRP1 NLGN2 MAPK8IP3

3.02e-0496362828671696
Pubmed

Complement Targets Newborn Retinal Ganglion Cells for Phagocytic Elimination by Microglia.

LRP1 RXRG

4.18e-041762230647151
Pubmed

Agrin has a pathological role in the progression of oral cancer.

MYH11 MAP1S SRP72 PCOLCE

4.31e-0419762429872149
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

DMXL2 MAP1S SGSM2 LRP1 TUBGCP5 RXRG MRFAP1L1 ZBED5 MAPK8IP3

4.34e-04128562935914814
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

PCNP GAPVD1 PHF3 HAUS5 BOD1L1 CLINT1

4.38e-0454962638280479
Pubmed

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

GAPVD1 NUMBL DUSP7 HAUS5 SRP72 CLINT1 ANKRD50 SPATA2

4.97e-04103862826673895
Pubmed

Ontogeny and Trophic Factor Sensitivity of Gastrointestinal Projecting Vagal Sensory Cell Types.

GLP1R GFRA1

5.24e-041962236973009
Pubmed

Preliminary evidence of genetic determinants of adiponectin response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network.

SCUBE1 C6

5.24e-041962223149075
Pubmed

Cryptochromes-Mediated Inhibition of the CRL4Cop1-Complex Assembly Defines an Evolutionary Conserved Signaling Mechanism.

PER2 FBXL3

5.82e-042062231155351
Pubmed

Cross-Linking Mass Spectrometry Uncovers Interactions Between High-Density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein.

MYH11 C6 SPINK5

6.05e-049262337343697
Pubmed

Functional proteomics mapping of a human signaling pathway.

LRP1 SRP72 ZZEF1 ANKLE2 ZBED5 INVS

6.44e-0459162615231748
Pubmed

Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

DMXL2 MYH11 HAUS5

7.71e-0410062310048485
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

PER2 PHF3 SGSM2 BOD1L1 SPATA2

8.02e-0440762512693553
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

GAPVD1 NUMBL PHF3 N4BP2 BOD1L1 CLINT1 LYST

8.38e-0486162736931259
Pubmed

Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

DHX36 GAPVD1 NLGN2

8.40e-0410362310819331
Pubmed

Identification of multi-SH3 domain-containing protein interactome in pancreatic cancer: a yeast two-hybrid approach.

GAPVD1 SRP72 BOD1L1

9.13e-0410662318654987
Pubmed

A G-quadruplex DNA structure resolvase, RHAU, is essential for spermatogonia differentiation.

DHX36 GFRA1

9.14e-042562225611385
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

DHX36 DMXL2 SRP72 ANKRD50 ZZEF1 PTK7

1.05e-0365062638777146
Pubmed

Numb family proteins are essential for cardiac morphogenesis and progenitor differentiation.

MYH11 NUMBL

1.07e-032762224335256
Pubmed

Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.

GAPVD1 NUMBL ADCK2 CLINT1

1.13e-0325562415324660
Pubmed

ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1.

DHX36 LRP1 SMOC1 ZZEF1 ADAM10 SLC39A13 PTK7 PCOLCE

1.28e-03120162835696571
Pubmed

LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.

GAPVD1 MYH11 SRP72 CLINT1 ANKLE2 ADAM10 PTK7

1.41e-0394262731073040
Pubmed

Characterization of long cDNA clones from human adult spleen.

SUDS3 MAPK8IP3

1.59e-033362211214971
ToppCellcellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PLPPR4 NUMBL SMOC1 GFRA1 PCOLCE

5.08e-06182615bb7de0c93d8f59f13c990e425139b9348ca8027e
ToppCellcellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PLPPR4 NUMBL SMOC1 GFRA1 PCOLCE

5.08e-06182615507f095af4dff60f2c2b64d750477154084c3595
ToppCellcellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

PLPPR4 NUMBL SMOC1 GFRA1 PCOLCE

5.08e-0618261588bd17c07bd8443a0ede4e9dc7bc9d1230b42211
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRP1 C1R NLGN2 GFRA1 PCOLCE

6.10e-06189615d531399749409d614adca13d181830c6e3287508
ToppCellFibroblasts|World / lung cells shred on cell class, cell subclass, sample id

MYH11 PLPPR4 C1R GFRA1 PCOLCE

7.83e-06199615e2b6752fcabd5249a166486ae6796f2c97c1fcaf
ToppCellTracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PLPPR4 LRP1 C1R GFRA1 PCOLCE

8.02e-062006158ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0
ToppCellTCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-4|TCGA-Bladder / Sample_Type by Project: Shred V9

SCUBE1 PER2 PLPPR4 GFRA1

5.34e-05150614bcb99c6fa81052556ab30f9db5875fccf1ae724b
ToppCellE16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PER2 MAP3K15 SMOC1 SP140

6.86e-05160614b2d8940ea8c068273b7da1589d3d6ae5110d8209
ToppCellE16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PER2 MAP3K15 SMOC1 SP140

6.86e-051606149caab1bb63c7e66c44783852ee75b16bb40fa594
ToppCellE16.5-Immune-Immune_Lymphocytic_T/NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PER2 MAP3K15 SMOC1 SP140

6.86e-05160614229841be7b984a00a301cd5d88c11226a90d8a88
ToppCellE16.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PER2 MAP3K15 SMOC1 SP140

6.86e-0516061499c9ae2041445539fada842e1af01368669bfca0
ToppCellAdult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor

MYH11 PLPPR4 KCNH2 GLP1R

9.08e-05172614c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf
ToppCellwk_08-11-Mesenchymal-Fibroblast-Airway_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

NUMBL LRP1 C1R ZBED5

9.29e-05173614b23b408acc29a667cce104429afef1a6cf2720a5
ToppCelltumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

PLPPR4 C1R GFRA1 PCOLCE

9.92e-05176614510f9a14dc1c151d24d079e0cc004cdf4f86336c
ToppCell343B-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells)

DMXL2 MYH11 CCDC190

1.02e-046661357fd31a25addc48793d7975eadccf4c5a41a8b03
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c08-IL2RB|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

HAUS5 MAP3K15 ZZEF1 SP140

1.06e-04179614db76edd368eeca05a2a5d407c3eb2f535ade0ce3
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LRP1 C1R SMOC1 PCOLCE

1.08e-04180614c2746092ef251e9d5910fe96461afdd0624a24c6
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LRP1 C1R SMOC1 PCOLCE

1.08e-0418061432c6a3886428d82fb4355d987c6d2645f333447b
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRP1 C1R GFRA1 PCOLCE

1.13e-04182614d179b5deb07c20d49eb6c58d5a65904f8921de3a
ToppCell3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

C1R SLC39A13 PTK7 PCOLCE

1.15e-04183614269afec240a756eec3bbae5f30ec784281af3433
ToppCellCV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster

DMXL2 GAPVD1 ADAM10 INVS

1.20e-04185614a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCelldroplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLINT1 ANKLE2 LYST GFRA1

1.20e-041856147adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCellCV-Moderate-7|CV / Virus stimulation, Condition and Cluster

DMXL2 GAPVD1 ADAM10 INVS

1.23e-041866148571956890fc9894d766ba294a28e376b4aba428
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

KRT85 C1R GFRA1 PCOLCE

1.23e-0418661407d94d5d1c2fe7bb909a07ca81058a0eabc65c60
ToppCelldroplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

KCNH2 KRT85 GFRA1 RXRG

1.25e-041876148e8b147258982b359447add5027318f5b6d51963
ToppCell10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

C1R SMOC1 RXRG PCOLCE

1.31e-04189614eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0
ToppCell10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

C1R SMOC1 RXRG PCOLCE

1.31e-0418961440764f461b8aa1d3a2c5a30590b7fb9307d47d09
ToppCelldroplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH11 PLPPR4 KCNH2 SMOC1

1.31e-041896144dc32b463546bbe7250dddd281b92ad17ec22da1
ToppCelldroplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH11 PLPPR4 KCNH2 SMOC1

1.31e-041896140d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f
ToppCellControl-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class

MYH11 SSH1 C1R LYST

1.33e-041906144e30155203b4a8c5e496fcbe9348b67b98ebc625
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DHX36 PHF3 CLINT1 ADAM10

1.36e-0419161460c986d2dcbc19d9338c03da6cb5e1d92fd48f8e
ToppCellPSB-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

SMIM24 KCNH2 SMOC1 GFRA1

1.36e-041916148f4637e801554e2343b974fe7794f01dd2151418
ToppCelldroplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NUMBL LRP1 PTK7 PCOLCE

1.36e-041916146cab0334f76c973880bd8d1638856f2f6e4a249a
ToppCellCD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster

GAPVD1 ADAM10 LYST INVS

1.36e-041916149454f642c3621370fa23640b631301346b300950
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PLPPR4 C1R GFRA1 PCOLCE

1.36e-041916140fae1c2ef9f83ac7721d0a9d69455bf97eed9257
ToppCelldroplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DHX36 PHF3 CLINT1 ADAM10

1.36e-04191614973117730d6ba5f127e7a0bfabfd0ff2ca7ac131
ToppCellwk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

MYH11 PLPPR4 KCNH2 PTK7

1.39e-041926147ae3e1ca8bfc078c0e12a1595ecb0e343dab5d2f
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

N4BP2 CD163L1 SMOC1 RXRG

1.39e-04192614025fac36b862f9ca7f96fb4a1946c44ba7cbc382
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PLPPR4 C1R GFRA1 PCOLCE

1.39e-04192614b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

MYH11 LRP1 C1R GFRA1

1.41e-04193614f1199518c3626fd29bfce65070dd21a660671213
ToppCellLPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LRP1 C1R GFRA1 PCOLCE

1.44e-041946146e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCellIPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class

MYH11 C1R C6 LYST

1.44e-04194614e8a9005963704286bcc50785bda8d7d63ec001b1
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

LRP1 C1R GFRA1 PCOLCE

1.44e-0419461489b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCellwk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

SCUBE1 MYH11 GFRA1 PTK7

1.47e-041956144dba732c8d8ecf0ed9ece1814dc4060402199ed9
ToppCellASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq

MYH11 PLPPR4 C1R PCOLCE

1.47e-041956142b156163975d9a3d3fda1402acd9831d0fdc9e25
ToppCell5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LRP1 C1R GFRA1 PCOLCE

1.47e-04195614fc43cd295f2cc3f6e9442232e028944f011c82cc
ToppCellASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq

MYH11 PLPPR4 C1R PCOLCE

1.47e-04195614c269c0d894a0f55da6495b59d4b9abb9f68df684
ToppCelltumor_Lung-Fibroblasts-Smooth_muscle_cells|tumor_Lung / Location, Cell class and cell subclass

MYH11 C1R GFRA1 PCOLCE

1.47e-04195614ea9ff25020c2fcd1bab80e1829af0f4e4777de8b
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

NUMBL LRP1 C1R PCOLCE

1.50e-04196614525d6c8a277364e624e7cc586275f8a891436b57
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PLPPR4 C1R GFRA1 PCOLCE

1.50e-04196614e7bfd4fb400ae0c473131d0fa306c26be08a6d03
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PLPPR4 C1R GFRA1 PCOLCE

1.50e-0419661482fad623212d986a7fca3496faf3f8c8f5b83a11
ToppCell5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LRP1 C1R PTK7 PCOLCE

1.50e-041966142ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PLPPR4 C1R GFRA1 PCOLCE

1.50e-0419661485e5046f774537684e1443c0fc147d562b7068d0
ToppCell10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

SCUBE1 LRP1 C1R PCOLCE

1.53e-041976145afddde4e2b5cd55abe11e9b9efae02dbdc3da3a
ToppCell10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

SCUBE1 LRP1 C1R PCOLCE

1.53e-041976141baffd087ca194a7355fefbb3bf67befb14fe2de
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRP1 C1R GFRA1 PCOLCE

1.53e-0419761471786e9432e2d649f5d86f639abb25e7102deb67
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYH11 C1R GFRA1 PCOLCE

1.53e-0419761416758f181ef07c60aee63072e1da9572c5c85414
ToppCell10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

SCUBE1 LRP1 C1R PCOLCE

1.53e-04197614b9745e382baa2725dfcae060701fb53f6c8a31fa
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

LRP1 C1R GFRA1 PCOLCE

1.53e-041976144cf4e9553397cd8dee883dbec24f41bec41aff99
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

DMXL2 MAP1S DUSP7 LRP1

1.53e-04197614280804810041783f1b7704914b62ffefbb0d88f6
ToppCellILEUM-inflamed-(8)_Pericytes|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

MYH11 PLPPR4 C1R PCOLCE

1.53e-04197614e04ac8575f66d798ddf2fd6d55d397a163b40732
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LRP1 C1R PTK7 PCOLCE

1.56e-0419861409be07ebfc3e49c3858e9b74605b69cf4fc28b56
ToppCelldistal-3-mesenchymal-Vascular_Smooth_Muscle|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MYH11 C1R GFRA1 PCOLCE

1.56e-0419861437ce7b485ffb207e75afd1b576b486c6d59fc136
ToppCelldistal-mesenchymal-Vascular_Smooth_Muscle|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MYH11 C1R GFRA1 PCOLCE

1.56e-041986148d1c74a728040386316fbdcabcdea5fb2b5a76a1
ToppCellParenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

SCUBE1 PLPPR4 GFRA1 PCOLCE

1.56e-04198614300d7cc56207d77168390fa1ffcbcf76767b1b80
ToppCellBronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

MYH11 PLPPR4 C1R PCOLCE

1.56e-04198614dc6d9032c5029527e184ac13b887c0c1f22ef1c0
ToppCelldistal-mesenchymal-Vascular_Smooth_Muscle-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MYH11 C1R GFRA1 PCOLCE

1.56e-041986145080767ff55326b7d94fca27d398237c4a15c1ed
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LRP1 C1R GFRA1 PCOLCE

1.56e-0419861475d104eead681f6bf47c4dd24913cc768c9a1717
ToppCell3'-Broncho-tracheal-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MYH11 C1R GFRA1 PCOLCE

1.56e-041986144961a3e9b953679648586afed04869ff36b81820
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRP1 C1R GFRA1 PCOLCE

1.59e-041996149672230aa0bc6a7289050c955f5154ca183a5159
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRP1 C1R GFRA1 PCOLCE

1.59e-04199614e18abe678da293bd01fae55e2f9ab6fdd643d02d
ToppCellLPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

MYH11 KCNH2 LRP1 PTK7

1.59e-0419961438cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCellILEUM-inflamed-(8)_Activated_fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

LRP1 C1R PTK7 PCOLCE

1.59e-04199614317f412996d463ddf2e6a52ff41d5d676c77f43f
ToppCellBronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

PLPPR4 C1R GFRA1 PCOLCE

1.59e-04199614e1f1950d6f840485e263b83dc81b98910be3ae7a
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRP1 C1R GFRA1 PCOLCE

1.59e-041996141fd7bbb8727607e6507848602a19bc86882ef2d5
ToppCellFibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

LRP1 C1R SMOC1 PCOLCE

1.59e-0419961413ff7409e200a0b46cdb7924d15ef33639693622
ToppCellLPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

MYH11 KCNH2 LRP1 PTK7

1.59e-041996146b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCelldistal-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

MYH11 C1R GFRA1 PCOLCE

1.59e-04199614b8f3cf5bcfde1066bdb49b14fdc842fe9692a6b7
ToppCell3'-Broncho-tracheal-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRP1 C1R GFRA1 PCOLCE

1.59e-04199614fb580e9321ddf97c73b2e356cd82523db74a38a2
ToppCell11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class

MYH11 PLPPR4 KCNH2 PTK7

1.59e-041996141a8c77d241bd817a195e1532fd25f51358cb1ff1
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

LRP1 C1R GFRA1 PCOLCE

1.62e-04200614ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCellBiopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type

MYH11 C1R GFRA1 PCOLCE

1.62e-0420061401522ed0b68614b1ebdf190957d44a9d48a6c6e3
ToppCellControl_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type

PLPPR4 LRP1 PTK7 PCOLCE

1.62e-0420061464ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRP1 C1R GFRA1 PCOLCE

1.62e-0420061417ffdbc13332bd3ed1d54abcd7af20267dd4b234
ToppCellNeuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TSPAN12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic

C6 SMOC1 ANKRD50 RXRG

1.62e-04200614523d799eb315b33b77e02d5b7db63dad8450c4e1
ToppCellCOVID-19|World / group, cell type (main and fine annotations)

DMXL2 LRP1 C1R ADAM10

1.62e-04200614ac38a468559c33ee00152735ce6e408f3f48df84
ToppCellParenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

LRP1 C1R GFRA1 PCOLCE

1.62e-04200614fc3c4778841c4b8bac0afb458352614b2c460617
ToppCell5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LRP1 C1R GFRA1 PCOLCE

1.62e-042006146f7f015b5fa1f52374f2c7d9ba339012395eda5f
ToppCellNeuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TSPAN12|Neuronal / cells hierarchy compared to all cells using T-Statistic

C6 SMOC1 ANKRD50 RXRG

1.62e-04200614e5cef95e563a6e793ade190ce88c999bfa0af460
ToppCell(6)_Stroma|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)

MYH11 C1R GFRA1 PCOLCE

1.62e-04200614f9baef67dde62f1c161a9408a78f635ea70ea9d3
ToppCellControl_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type

MYH11 KCNH2 LRP1 PTK7

1.62e-04200614a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell(6)_Stroma|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)

MYH11 C1R GFRA1 PCOLCE

1.62e-04200614f0818821c495022569aef2c1886d9f2446dc027e
ToppCelltumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

PLPPR4 C1R GFRA1 PCOLCE

1.62e-042006144f7e26b27bd51c32420ed8c2f52d070aee542159
ToppCellTracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

MYH11 SSH1 CD163L1 DUSP7

1.62e-04200614410b1a31de21c57d87ca2104f61cf4a7d4dd2f30
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

MYH11 KCNH2 LRP1 PTK7

1.62e-0420061409537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRP1 C1R GFRA1 PCOLCE

1.62e-042006142e4ab7fbd94d3d865ef6188d3b4916d2bf1b8d89
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LRP1 C1R GFRA1 PCOLCE

1.62e-04200614665df8391d2ebcfc6536318612f4992852b5e2b8
ToppCellcellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

LRP1 C1R GFRA1 PCOLCE

1.62e-0420061444317fbf4d1480a37b50ab2777bf1a3e4fc0c05f
ToppCell3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LRP1 C1R PTK7 PCOLCE

1.62e-042006143dacd0afe69bc16bb33336ea9ea99a9cd47731d9
ToppCellTracheal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

LRP1 C1R GFRA1 PCOLCE

1.62e-04200614f74b9b0e27afedd589e828d30194e8417029817a
DrugMonensin sodium salt [22373-78-0]; Down 200; 5.8uM; MCF7; HT_HG-U133A

CAPN9 PER2 MAB21L4 ZZEF1 MAPK8IP3 SPINK5

1.60e-051976264726_DN
DrugMerbromin [129-16-8]; Down 200; 5uM; MCF7; HT_HG-U133A

CAPN9 PER2 MAB21L4 DUSP7 ZZEF1 MAPK8IP3

1.64e-051986264722_DN
DrugFenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A

CAPN9 KRT85 GLP1R LRP1 ZZEF1 SPINK5

1.74e-052006263714_UP
DrugLY294002; Down 200; 10uM; MCF7; HG-U133A

DUSP7 HAUS5 LRP1 ANKLE2 RXRG SPINK5

1.74e-05200626318_DN
Diseasemigraine without aura, susceptibility to, 4

LRP1 GFRA1

4.63e-0416592MONDO_0011847
Diseasecoronary artery disease

SCUBE1 MYH11 MAP1S LRP1 C1R ANKRD50 SPATA2 MAPK8IP3 PTK7

5.73e-041194599EFO_0001645
Diseasesciatic neuropathy (biomarker_via_orthology)

LRP1 NLGN2 GFRA1

1.04e-0399593DOID:11446 (biomarker_via_orthology)
DiseaseComplement deficiency disease

C1R C6

1.99e-0333592C0272242

Protein segments in the cluster

PeptideGeneStartEntry
ARASECRDVEGFKTE

ADCK2

531

Q7Z695
STREDAEKFARGICD

ANKLE2

241

Q86XL3
TGEREASCRDKATTS

ANKLE2

616

Q86XL3
SEKCRDDSDCAREGI

ADAM10

521

O14672
KVDCADADSRTALRA

ANKRD50

636

Q9ULJ7
TELDESRDKSCSGRD

DMXL2

1546

Q8TDJ6
SRDKSCSGRDTLDEC

DMXL2

1551

Q8TDJ6
RSDAGVICSDKADLD

CD163L1

461

Q9NR16
VDLDECASRSKSGEE

C1R

141

P00736
RREKECGVTAAFDAS

NUMBL

201

Q9Y6R0
SDDSRRLGKFCGDAV

PCOLCE

226

Q15113
SSDDEDCSAKGRNRH

INTS10

381

Q9NVR2
SGEADERVSELCEKA

MRFAP1L1

86

Q96HT8
EDTFTASSEGDAKCR

MAB21L4

126

Q08AI8
ACEAASRLARGEDEA

MAP1S

341

Q66K74
RKDREDSPERCSDSD

CLINT1

221

Q14677
CSDSDEEKKARRGRS

CLINT1

231

Q14677
DDDCTSSARREQKRE

MAPK8IP3

631

Q9UPT6
REAECVEADSGRLAS

KRT85

181

P78386
RDLSECEESKRGERS

GLP1R

121

P43220
CTRESDPVRDADGKS

SPINK5

721

Q9NQ38
FRLKDDGRTCADVDE

LRP1

2971

Q07954
KIEDLRSECSSDFGG

GAPVD1

781

Q14C86
CASVRRASSADDIEA

KCNH2

276

Q12809
ESSSSRAGKECENRV

CCDC190

281

Q86UF4
RDSQGSDCDDSGKEL

PER2

51

O15055
SRSAEKRSAEEEAAD

PCNP

46

Q8WW12
DCSRGAEDEVSSRAK

OR2W5P

221

A6NFC9
ESTTCQAGARDAERK

TUBGCP5

576

Q96RT8
AAEREAEIRSLCSGD

HAUS5

251

O94927
CARAKEEAGATAADE

H1-7

201

Q75WM6
SAGSEEKCDGSLSRD

BOD1L1

1656

Q8NFC6
SDDSTRKCTGEERIG

GRM6

376

O15303
SSSDAEELERCREAA

CUSTOS

16

Q96C57
DNSDERDCGRTKAVC

C6

166

P13671
SLASGLEAKDECRSA

GFRA1

61

P56159
RDSDRNSSEEGTAEK

FBXL3

6

Q9UKT7
SVAERVAAERAESCG

DHX36

271

Q9H2U1
RISSDCSDGESDREL

DUSP7

211

Q16829
FLCVSKEAESDRESA

LYST

906

Q99698
GKECRAESCLDRRSE

IP6K1

341

Q92551
GCFIDTRSAAESEAR

CAPN9

231

O14815
ASDTCEADCLRKRAE

SCUBE1

561

Q8IWY4
GTATACRLDNKESES

SLC39A13

41

Q96H72
LAAKVGCDREDSAEA

NLGN2

311

Q8NFZ4
SVEKSRGETAGDERC

INVS

721

Q9Y283
IFLDSDCKDDTSRDS

MAP3K15

371

Q6ZN16
SGSASEDRLAACARE

SGSM2

231

O43147
CSKARAEDEEETTFR

SMIM24

56

O75264
KAEDLCRRSLSEDTD

SRP72

201

O76094
CRRSLSEDTDGTEED

SRP72

206

O76094
KEGLRCRSDSEDECS

PI4KAP2

286

A4QPH2
TASGAPEASRERCED

SSH1

656

Q8WYL5
SKCSDGERARAELND

MYH11

1266

P35749
ESCESLKDSFGSGDR

PLPPR4

671

Q7Z2D5
SCESDARAKTTEADD

SMOC1

291

Q9H4F8
ERKSSAEDVRGCSDA

SPATA2

196

Q9UM82
KRESGEGRNSSDCRD

PHF3

831

Q92576
DACALASDKSRDRFS

TLNRD1

196

Q9H1K6
SRERAESEAECATSG

RXRG

216

P48443
VCSDASRAVDGKIAE

ZBED5

341

Q49AG3
KSRIGCSSDDLGEDD

ZZEF1

636

O43149
EKALETCGAGRSESE

TSPYL6

126

Q8N831
CDGEERQEASSSLAR

SP140

396

Q13342
ESAEDDERSCRGRES

SUDS3

31

Q9H7L9
CVARDDVTGEEARSA

PTK7

101

Q13308
ESVEDGRKSQCDDAS

N4BP2

846

Q86UW6